CD8+ T cells from Theiler's virus-resistant BALB/cByJ mice downregulate pathogenic virus-specific CD4+ T cells

Journal of Neuroimmunology

Volumn 106, Issue 1-2, 2000, Pages 43-52

  Haynes, Lia M ^a   Vanderlugt, Carol L ^a   Dal Canto, Mauro C ^a   Melvold, Roger W ^b   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

EAE MS; Mouse; Neuroimmunology; T lymphocytes; TMEV

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE RESISTANCE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ANIMALS; CARDIOVIRUS INFECTIONS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CYTOKINES; DEMYELINATING DISEASES; DISEASE SUSCEPTIBILITY; DOWN-REGULATION; HYPERSENSITIVITY, DELAYED; MICE; MICE, INBRED BALB C; TH1 CELLS; THEILOVIRUS;

EID: 0034237632     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00212-5     Document Type: Article

References (41)

1. Allen I., Brankin B. Pathogenesis of multiple sclerosis: the immune diathesis and the role of viruses. J. Neuropathol. Exp. Neurol. 52:1993;95-105.
2. + T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J. Gen. Virol. 73:1992;1861-1865.
3. Cavanaugh V.J., Guidotti L.G., Chisari F.V. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J. Virol. 72:1998;2630-2637.
4. Clatch R.J., Melvold R.W., Miller S.D., Lipton H.L. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135:1985;1408-1414.
5. Clatch R.J., Lipton H.L., Miller S.D. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 136:1986;920-927.
6. Cook S.D., Rohowsky-Kochan C., Bansil S., Dowling P.C. Evidence for multiple sclerosis as an infectious disease. Acta Neurol. Scand. 161:1995;34-42.
7. Dal Canto M.C., Lipton H.L. Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab. Invest. 33:1975;626-637.
8. + T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152:1994;919-929.
9. + T and NK cells. J. Exp. Med. 180:1994;1937-1942.
10. Guidotti L.G., Ando K., Hobbs M.V., Ishikawa T., Runkel L., Schreiber R.D., Chisari F.V. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA. 91:1994;3764-3768.
11. Guidotti L.G., Ishikawa T., Hobbs M.V., Matzke B., Schreiber R., Chisari F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:1996;25-36.
12. + T cell clones producing immune suppressive lymphokines IL-10 and interferon-gamma. Cell. Immunol. 154:1994;181-192.
13. + suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms. J. Immunol. 150:1993;2121-2128.
14. + T cells expressing V beta 8 TCR: a role of the Qa-1 molecule. Immunity. 2:1995;185-194.
15. + T cells. Proc. Natl. Acad. Sci. USA. 95:1998;4533-4537.
16. Johnson R.T. The virology of demyelinating diseases. Ann. Neurol. Suppl. 36:1994;S54-S60.
17. Karpus W.J., Pope J.G., Peterson J.D., Dal Canto M.C., Miller S.D. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 155:1995;947-957.
18. Kurtzke J.F. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6:1993;382-427.
19. Lipton H.L. Theiler's virus infection in mice: An unusual biphasic disease process leading to demyelination. Infect. Immun. 11:1975;1147-1155.
20. Lipton H.L., Melvold R. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J. Immunol. 132:1984;1821-1825.
21. Melvold R.W., Jokinen D.M., Miller S.D., Dal Canto M.C., Lipton H.L. H-2 genes in TMEV-induced demyelination, a model for multiple sclerosis. David C.S. H-2 Antigens. 1987;735-745 Plenum Press, New York.
22. Melvold R.W., Jokinen D.M., Knobler R.L., Lipton H.L. Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell beta-chain constant gene on chromosome 6. J. Immunol. 138:1987;1429-1433.
23. Melvold R.W., Jokinen D.M., Miller S.D., Dal Canto M.C., Lipton H.L. Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 64:1990;686-690.
24. Miller S.D., Gerety S.J. Immunologic aspects of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. Semin. Virol. 1:1990;263-272.
25. Miller S.D., Clatch R.J., Pevear D.C., Trotter J.L., Lipton H.L. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. J. Immunol. 138:1987;3776-3784.
26. Miller S.D., Gerety S.J., Kennedy M.K., Peterson J.D., Trotter J.L., Tuohy V.K., Waltenbaugh C., Dal Canto M.C., Lipton H.L. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. J. Neuroimmunol. 26:1990;9-23.
27. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., Katz-Levy Y., Carrizosa A., Kim B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1997;1133-1136.
28. Nicholson S.M., Peterson J.D., Miller S.D., Dal Canto M.C., Melvold R.W. BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. J. Neuroimmunol. 52:1994;19-24.
29. + lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice. J. Immunol. 156:1996;1276-1283.
30. + T cells in resistance of BALB/c mice to TMEV-induced demyelinating disease: regulatory vs. lytic. J. Neuroimmunol. 98:1999;136-146.
31. Olsberg C., Pelka A., Miller S.D., Waltenbaugh C., Creighton T.M., Dal Canto M.C., Lipton H., Melvold R. Induction of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice. Regul. Immunol. 5:1993;1-10.
32. + T cell clone, I.S. 2.15, has in vitro immunosuppressive properties. Eur. J. Immunol. 22:1992;2017-2023.
33. Pelka A., Olsberg C., Miller S.D., Waltenbaugh C., Creighton T.M., Dal Canto M.C., Melvold R. Effects of irradiation on development of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice. Cell. Immunol. 152:1993;440-455.
34. Pena Rossi C., McAllister A., Fiette L., Brahic M. Theiler's virus infection induces a specific cytotoxic T lymphocyte response. Cell. Immunol. 138:1991;341-348.
35. + T cell-mediated pathology. J. Immunol. 156:1996;4050-4058.
36. Pullen L.C., Miller S.D., Dal Canto M.C., Kim B.S. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23:1993;2287-2293.
37. + T cells. J. Immunol. 155:1995;609-618.
38. Rodriguez M., Leibowitz J., David C.S. Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J. Exp. Med. 163:1986;620-631.
39. Rodriguez M., Patick A.K., Pease L.R. Abrogation of resistance to Theiler's virus-induced demyelination in C57BL mice by total body irradiation. J. Neuroimmunol. 26:1990;189-199.
40. Tsui L.V., Guidotti L.G., Ishikawa T., Chisari F.V. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. Natl. Acad. Sci. USA. 92:1995;12398-12402.
41. + cells in myasthenia gravis patients and in healthy controls. J. Immunol. 154:1995;1508-1520.